Biomedicine & Pharmacotherapy
ISSN 0753-3322 · Elsevier BV · France · active 1982–2026
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Indexing & access
Access status: gold. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Biomedicine & Pharmacotherapy a predatory journal?
Our screening does not flag Biomedicine & Pharmacotherapy. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.
Is Biomedicine & Pharmacotherapy indexed in Scopus or Web of Science?
Per our venue index, Biomedicine & Pharmacotherapy appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is Biomedicine & Pharmacotherapy's impact?
Papers in Biomedicine & Pharmacotherapy are cited about 7.1 times each within two years of publication, and Scimago places it in Q1, with an h-index of 218. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.
Is Biomedicine & Pharmacotherapy open access?
Our index records its access status as "gold". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.